Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer

Recombinant adeno-associated viruses (AAVs) have emerged as promising gene delivery vehicles resulting in three US Food and Drug Administration (FDA) and one European Medicines Agency (EMA)-approved AAV-based gene therapies. Despite being a leading platform for therapeutic gene transfer in several c...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjomandnejad, Motahareh, Dasgupta, Ishani, Flotte, Terence R., Keeler, Allison M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979149/
https://www.ncbi.nlm.nih.gov/pubmed/36862289
http://dx.doi.org/10.1007/s40259-023-00585-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979149/
https://www.ncbi.nlm.nih.gov/pubmed/36862289
http://dx.doi.org/10.1007/s40259-023-00585-7

Ejemplares similares